Page last updated: 2024-08-25

chitosan and norcantharidin

chitosan has been researched along with norcantharidin in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's12 (92.31)24.3611
2020's1 (7.69)2.80

Authors

AuthorsStudies
Bei, YY; Hu, W; Hu, ZH; Wang, Q; Wang, WJ; Xu, JY; Zhang, L; Zhang, Q; Zhang, XN1
Bei, YY; Guan, M; Liu, Y; Zhang, Q; Zhang, XN; Zhou, Y; Zhu, QL1
Bei, YY; Gu, ZL; Guan, M; Liu, Y; Zhang, Q; Zhang, XN; Zhu, QL1
Chen, WL; Ding, XY; Gu, ZL; Hong, CJ; Liu, Y; Shi, LS; Xing, KL; Zhang, Q; Zhang, XN; Zhu, AJ1
Bei, YY; Chen, WL; Chen, XY; Gu, ZL; Liu, Y; Shi, LS; Wang, Q; Wang, WJ; Xing, KL; Xu, JY; Zhang, Q; Zhang, XN; Zhu, AJ1
Guo, A; Guo, S; Jiang, J; Li, M; Li, Y; Liu, J; Lv, L; Shen, Y; Wang, F; Xu, X1
Guo, S; Li, Y; Shen, Y; Xu, X1
Guo, S; Li, M; Lu, F; Xu, X1
Chi, J; Han, B; Jiang, Z; Liu, W1
Chi, J; Han, B; Jiang, Z; Liu, W; Peng, Y; Qiao, J1
Chi, J; Han, B; Jiang, Z; Liu, W; Peng, Y; Qiao, J; Zhang, W1
Chen, X; Chi, J; Han, B; Jiang, Z; Liu, W; Peng, Y1
Huang, Z; Liu, C; Lu, R; Lu, Y; Song, K; Sun, H; Wang, Q; Zhao, F; Zheng, C1

Other Studies

13 other study(ies) available for chitosan and norcantharidin

ArticleYear
Norcantharidin-associated galactosylated chitosan nanoparticles for hepatocyte-targeted delivery.
    Nanomedicine : nanotechnology, biology, and medicine, 2010, Volume: 6, Issue:2

    Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Carcinoma, Hepatocellular; Cell Line, Tumor; Chitosan; Drug Carriers; Galactose; Liver Neoplasms; Mice; Nanoparticles

2010
N-trimethyl chitosan nanoparticle-encapsulated lactosyl-norcantharidin for liver cancer therapy with high targeting efficacy.
    Nanomedicine : nanotechnology, biology, and medicine, 2012, Volume: 8, Issue:7

    Topics: Animals; Antineoplastic Agents; Apoptosis; Bridged Bicyclo Compounds, Heterocyclic; Carcinoma, Hepatocellular; Chitosan; Drug Delivery Systems; Hep G2 Cells; Humans; Liver; Liver Neoplasms; Male; Mice; Nanoparticles

2012
Uptake and transport of a novel anticancer drug-delivery system: lactosyl-norcantharidin-associated N-trimethyl chitosan nanoparticles across intestinal Caco-2 cell monolayers.
    International journal of nanomedicine, 2012, Volume: 7

    Topics: Biological Transport; Bridged Bicyclo Compounds, Heterocyclic; Caco-2 Cells; Chitosan; Chromatography, High Pressure Liquid; Drug Carriers; Endocytosis; Humans; Hydrogen-Ion Concentration; Lactose; Nanoparticles; Particle Size; Temperature

2012
Pharmacokinetics, tissue distribution, and metabolites of a polyvinylpyrrolidone-coated norcantharidin chitosan nanoparticle formulation in rats and mice, using LC-MS/MS.
    International journal of nanomedicine, 2012, Volume: 7

    Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Chitosan; Chromatography, Liquid; Female; Male; Mice; Mice, Inbred ICR; Microscopy, Atomic Force; Nanomedicine; Nanoparticles; Povidone; Rats; Rats, Sprague-Dawley; Tandem Mass Spectrometry; Tissue Distribution

2012
Novel norcantharidin-loaded liver targeting chitosan nanoparticles to enhance intestinal absorption.
    International journal of nanomedicine, 2012, Volume: 7

    Topics: Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bridged Bicyclo Compounds, Heterocyclic; Chitosan; Drug Carriers; Drug Delivery Systems; In Vitro Techniques; Intestinal Absorption; Liver; Male; Microscopy, Electron, Transmission; Nanomedicine; Nanoparticles; Rats; Rats, Sprague-Dawley

2012
Synthesis, in vitro and in vivo evaluation of new norcantharidin-conjugated hydroxypropyltrimethyl ammonium chloride chitosan derivatives as polymer therapeutics.
    International journal of pharmaceutics, 2013, Sep-10, Volume: 453, Issue:2

    Topics: Animals; Antineoplastic Agents; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cell Survival; Chitosan; Endocytosis; Humans; Male; Mice; Neoplasms; Polymers; Quaternary Ammonium Compounds

2013
Synthesis and in vitro cellular evaluation of novel anti-tumor norcantharidin-conjugated chitosan derivatives.
    International journal of biological macromolecules, 2013, Volume: 62

    Topics: Antineoplastic Agents; Apoptosis; Bridged Bicyclo Compounds, Heterocyclic; Cell Cycle; Cell Line, Tumor; Chitosan; Drug Carriers; Humans; Nuclear Magnetic Resonance, Biomolecular; Solubility; Spectroscopy, Fourier Transform Infrared

2013
Primary in vitro and in vivo evaluation of norcantharidin-chitosan/poly (vinyl alcohol) for cancer treatment.
    Drug delivery, 2014, Volume: 21, Issue:4

    Topics: Animals; Antineoplastic Agents; Apoptosis; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Chitosan; Drug Evaluation, Preclinical; Female; Humans; Mice; Polyvinyl Alcohol; Treatment Outcome; Xenograft Model Antitumor Assays

2014
Preparation and pharmacological evaluation of norcantharidin-conjugated carboxymethyl chitosan in mice bearing hepatocellular carcinoma.
    Carbohydrate polymers, 2017, Oct-15, Volume: 174

    Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Carcinoma, Hepatocellular; Chitosan; Drug Carriers; Liver Neoplasms, Experimental; Mice; Xenograft Model Antitumor Assays

2017
Synthesis and anti-metastasis activities of norcantharidin-conjugated carboxymethyl chitosan as a novel drug delivery system.
    Carbohydrate polymers, 2019, Jun-15, Volume: 214

    Topics: A549 Cells; Animals; Antineoplastic Agents; Bridged Bicyclo Compounds, Heterocyclic; Carbohydrate Sequence; Carcinoma, Lewis Lung; Cell Movement; Chitosan; Down-Regulation; Drug Carriers; Female; Humans; Lung; Male; Matrix Metalloproteinase 9; Mice, Inbred C57BL; Neovascularization, Pathologic; Solubility; Tissue Inhibitor of Metalloproteinase-1; Vascular Endothelial Growth Factor A

2019
Antitumor evaluation of carboxymethyl chitosan based norcantharidin conjugates against gastric cancer as novel polymer therapeutics.
    International journal of biological macromolecules, 2019, Sep-01, Volume: 136

    Topics: Animals; Antineoplastic Agents; Apoptosis; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Chitosan; Female; Humans; Mice; Stomach Neoplasms; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays

2019
Studies on anti-hepatocarcinoma effect, pharmacokinetics and tissue distribution of carboxymethyl chitosan based norcantharidin conjugates.
    Carbohydrate polymers, 2019, Dec-15, Volume: 226

    Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Carcinoma, Hepatocellular; Cell Line, Tumor; Chitosan; Drug Carriers; Humans; Liver Neoplasms; Mice

2019
Strontium/Chitosan/Hydroxyapatite/Norcantharidin Composite That Inhibits Osteosarcoma and Promotes Osteogenesis In Vitro.
    BioMed research international, 2020, Volume: 2020

    Topics: Animals; Antineoplastic Agents; Apoptosis; Biocompatible Materials; Bone Development; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cell Proliferation; Chitosan; Freeze Drying; Humans; Hydroxyapatites; Microscopy, Electron, Scanning; Nanoparticles; Necrosis; Osteoblasts; Osteogenesis; Osteosarcoma; Particle Size; Sincalide; Spectroscopy, Fourier Transform Infrared; Strontium; X-Ray Diffraction

2020